FOLLICULAR THYROID CANCER

This adverse event was reported 162 times

These drugs are most commonly taken by patients reporting FOLLICULAR THYROID CANCER:

# Drug Count
0 LIRAGLUTIDE 14
1 LEVOTHYROXINE SODIUM 12
2 ADALIMUMAB 11
3 METHOTREXATE SODIUM 10
4 METHOTREXATE 9
5 EXENATIDE 8
6 ORAL SEMAGLUTIDE 8
7 GABAPENTIN 7
8 MELPHALAN HYDROCHLORIDE 7
9 PREDNISONE 7
See all common drugs associated with FOLLICULAR THYROID CANCER

FOLLICULAR THYROID CANCER is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 BROMOCRIPTINE MESYLATE 1 0.0015
1 THYROTROPIN ALFA 1 0.0010
2 CHLORZOXAZONE 1 0.0008
3 EMPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE 2 0.0007
4 IRON DEXTRAN 1 0.0007
5 EMPAGLIFLOZIN, METFORMIN HYDROCHLORIDE 2 0.0006
6 BRODALUMAB 1 0.0005
7 FLUVOXAMINE MALEATE 1 0.0004
8 CEVIMELINE HYDROCHLORIDE 1 0.0004
9 SORAFENIB 7 0.0003
See all drugs enriched for association with FOLLICULAR THYROID CANCER

FOLLICULAR THYROID CANCER is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Interleukin-5 Antagonist [EPC] 1 0.0015
1 Thyroid Stimulating Hormone [EPC] 1 0.0010
2 Interleukin-17 Receptor A Antagonist [EPC] 1 0.0005
3 Carnitine Analog [EPC] 1 0.0003
4 Antihypoglycemic Agent [EPC] 1 0.0002
5 Provitamin D2 Compound [EPC] 5 0.0002
6 Vitamin D2 Analog [EPC] 1 0.0001
7 Allylamine Antifungal [EPC] 1 0.0001
8 GLP-1 Receptor Agonist [EPC] 33 0.0001
9 Androgen [EPC] 2 0.0001
See all drug classes enriched for association with FOLLICULAR THYROID CANCER